Thu, Dec 18, 2014, 3:26 PM EST - U.S. Markets close in 34 mins.


% | $
Quotes you view appear here for quick access.

Transition Therapeutics Inc. Message Board

uss_muliphen 36 posts  |  Last Activity: Dec 11, 2014 4:26 PM Member since: Jan 21, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Gee rmg3144 Deleted his "RMTI hopes" post ?

    by uss_muliphen Dec 11, 2014 4:02 PM
    uss_muliphen uss_muliphen Dec 11, 2014 4:26 PM Flag

    Yeah, I'm thinking he gets dunce cap, and market cap mixed up.

  • uss_muliphen uss_muliphen Dec 10, 2014 2:23 PM Flag

    What do looking at what options are, have to do with where the stock price is going ?

    If options were a solid gold indicator of future stock prices, none of us would have ever had to punch a clock.

    All we'd have to do is look to the options traders .

  • Reply to

    High Expectations and RMTI....

    by sahmdars Dec 7, 2014 7:33 PM
    uss_muliphen uss_muliphen Dec 8, 2014 11:10 AM Flag

    Under the Distribution Agreement, Baxter will purchase products from the Company at pre-determined gross margin-based prices per unit, adjusted each year during the term and subject to an annual true up. Rockwell will continue to manage customer service, transportation and certain other functions for its current customers through at least December 31, 2017, for which Baxter will pay the Company an amount equal to the Company's related costs plus a slight mark-up. The Distribution Agreement requires Baxter to meet minimum annual purchase requirements (subject to a cure period and certain other relief) in order to maintain its exclusive distribution rights. The minimum purchase levels increase each year over the term of the Distribution Agreement. Purchases that exceed the minimum requirement in a given year may be carried forward and applied to future years' requirements.

    We expect the distribution relationship with Baxter under the Distribution Agreement to have a positive impact on our operating profit. Our operating costs will decrease and operating income will improve. Initially, our current sales level will decrease, but going forward we expect our overall domestic and global concentrate sales to increase as a result of the expanded marketing reach by Baxter, coupled with the anticipated expansion of our manufacturing operations in the Western United States.

    "Baxter will pay the Company an amount equal to the Company's related costs plus a slight mark-up."

  • Reply to

    High Expectations and RMTI....

    by sahmdars Dec 7, 2014 7:33 PM
    uss_muliphen uss_muliphen Dec 8, 2014 10:45 AM Flag

    For all here speculating on sales figures etc., do yourself a favor and peruse through the recent SEC filings, and you will see that the company is actually expecting a decrease initially in sales, it does not explain why, but that is what they are saying.

    So to me it looks like the stock is taking a wait and see attitude on a few things.

  • Reply to

    FDA approval

    by justawelder101 Dec 7, 2014 10:20 AM
    uss_muliphen uss_muliphen Dec 8, 2014 10:30 AM Flag

    justawelder The FDA "panel" is not the FDA itself, the panel is just a group of doctors/physicians selected by the actual FDA to review the drug in question and give their opinion.

    The actual FDA does not have sufficient personnel to review every drug coming up for approval all by themselves, so they select others in that particular field to look the situation over and point out the positives, or negatives.

    For my money I would really like to know what the 3 against approval did not like.

    I previously had another situation similar to this where the AdCom vote was 15-1, and the 1 turned out to be the loudest and most persistent against approval, and he turned out to be convincing to the FDA.

    We'll see.

  • Reply to


    by pennyvulture Dec 5, 2014 4:00 PM
    uss_muliphen uss_muliphen Dec 5, 2014 4:17 PM Flag

    pennyvulture Since you look at the chart, do you ever look at the Chaikin Money Flow (CMF) or the Bollinger Bands (BB) ?

  • Reply to

    New Guy in Town

    by biomaniac007 Dec 4, 2014 9:18 PM
    uss_muliphen uss_muliphen Dec 5, 2014 2:37 PM Flag

    zing Very sensible honest post.

  • Reply to

    Low volume ,shares drying up ....

    by thefax0056 Dec 5, 2014 2:03 PM
    uss_muliphen uss_muliphen Dec 5, 2014 2:33 PM Flag

    You are correct, many people forget, or are not aware of tax-loss selling season.

    If someone has taken profits on this, or any other stock during 2014 they will have to pay capital gains on those profits, so to offset those profits they sell their losers before year-end to avoid the capital gains tax.

    I'm not trying to insult anybody's intelligence here, I have just noticed on many other boards that year-end tax-loss selling is not a subject many are aware of.

    Stocks that are already down for the year get added pressure this time of year because of tax-loss selling.

  • Reply to

    Next Week....

    by renalman55 Dec 3, 2014 7:17 PM
    uss_muliphen uss_muliphen Dec 3, 2014 8:29 PM Flag

    renalman : In my opinion you're about one of the best informed posters on this board, but I have to say you clearly didn't think this comment out......." As I said earlier maybe Rockwell will purchase some of its own shares with a portion of those millions that are sitting just sitting there."

    Think about it.......They are going to issue shares, to get money to buyback shares ?

  • uss_muliphen uss_muliphen Dec 3, 2014 3:24 PM Flag

    Funny how I got all thumbs down on my other post also of...."Apparently Most Of You People Have Not Experienced A Secondary stock offering before."

    But was I wrong ?

    Basically I just try and rely on plain old common sense, it usually is the best tool we have most of the time.

  • uss_muliphen uss_muliphen Dec 3, 2014 2:44 PM Flag

    One thing I never do is put much stock in what option traders are doing, they to me are just people that for the most part don't have the capital to buy the actual stock.

    Most are rooky gamblers. I know I'm stepping on toes here with my opinion, but personally I have never seen a successful option trader.

    If you watch those "professional" option monster brothers on CNBC, they are 50/50 at best with their calls.

  • Only problem is, at the rate it is now going it will only be $4 by then.

  • Reply to


    by posiedon59 Dec 2, 2014 2:19 PM
    uss_muliphen uss_muliphen Dec 2, 2014 3:39 PM Flag

    "No one forced the management to sell stocks, they could have waited if they wanted to."

    I think the majority here totally agree on that.

    Management does not decide the price............they just decide to make the offering.

    Without the offering there would be no debate concerning the price.

    And like you say, they could have waited.......if they wanted to.

    With all the Baxter backing, there is/was no urgent need for any offering.

    I bet Baxter would have liked to get $15 Million worth of stock at $9.

  • Reply to


    by posiedon59 Dec 2, 2014 2:19 PM
    uss_muliphen uss_muliphen Dec 2, 2014 3:04 PM Flag

    "Do you think they should be pumping this stock when an FDA decision is imminent?"


    But not deflating it as well.

  • Reply to

    shorted @12 & some change..

    by johndrew101 Nov 28, 2014 1:16 PM
    uss_muliphen uss_muliphen Nov 30, 2014 1:38 PM Flag

    justawelder: john Is giving the 101's a bad name, I can see he is no kin to you. Personally I think he was lost, and didn't really intend to be posting here.

    He's probably over at Barnes and Nobles right now looking for a Dummies R US book on where, and where not to be posting on Yahoo.

  • Reply to

    shorted @12 & some change..

    by johndrew101 Nov 28, 2014 1:16 PM
    uss_muliphen uss_muliphen Nov 28, 2014 2:27 PM Flag

    Can you be a touch more descriptive than "voodoo medicine" ? Or just remain looking like an idiot and leave it at "voodoo medicine" ?

    And just for your information, nobody here believes your B.S. that you shorted @ 12 & some change.

    Your name followed by "101" indicates you're still a novice at lying on these message boards, you'll have to refine it a little to get even a scintilla of credibility.

    Moron !

  • uss_muliphen uss_muliphen Nov 26, 2014 3:31 PM Flag

    "ignoreland" ?

    Is that the same as bury your head in the sandland ?

    So I guess your off to the pie in the sky land.

  • uss_muliphen uss_muliphen Nov 26, 2014 1:37 PM Flag

    Who wants to pay more than the secondary issue price ?

    Not many.

    Maybe in January if things go right. But now I'd be willing to bet it's a waiting game.

    Let's hope the market doesn't fall apart beforehand.

  • Secondary stock offering before. In most cases when the offering price is announced, the majority of people do not want to pay more for the stock than what the offering price is.

    The thinking is, why should I pay more for the stock than what they are selling a ton of it to someone else for ?

    This is not uncommon at all. Very rarely does the stock appreciate much above the offering price, not that it never will, but the immediate thinking to shareholders is that they've been jilted.

  • Reply to

    The Management Answer.....

    by sahmdars Nov 21, 2014 2:47 PM
    uss_muliphen uss_muliphen Nov 21, 2014 5:04 PM Flag

    sahmdars You misunderstood my post, I was addressing your comment that in a couple of months the stock could be 14 or 20. What I'm saying that management absolutely knows there is no guarantee of an FDA approval, and they are taking a policy out on that for themselves by raising capital right now, to guarantee their future paychecks.

    And even if there is an FDA approval, that in itself is by no means a guarantee of sales.

    For example, look at AFFY, got an FDA approval, was $26 1/2 , now......less than one dollar. In the same category of business as RMTI, for CKD.

    After almost 100,000 applications of their drug, 2 patients died, now they are history.

    And there was a lot of speculation that these two patients were so sick that they more than likely died regardless of AFFY's drug, didn't matter, the drug was pulled.

    And they had the backing/partnership of a large Japanese company.

    Another example of a company with a new FDA approved drug, EPIX.

    Even if it comes, FDA approval is no guarantee for anything.

    Some here may be aware of AFFY, I am well aware of what happened to the stock price in one day. Today unchanged at 9 cents.

6.63+0.08(+1.22%)Dec 18 2:22 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.